Sofinnova Venture Partners IX, L.P. is 10% Owner at NextCure, Inc. (NXTC). They have made 2 open-market trades across 1 company since 2019, most recently 2019-11-15.
CIK 0001612133
2 open-market purchases totalling $11.5M since 2019, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.